| ۴۱ | Morphological Changes Induced By Extremely Low-Frequency Electric Fields | Imani, M., Kazemi, S., Saviz, M., (...), Sadeghi, B., Faraji-dana, R. | Bioelectromagnetics | 2019 |
| ۴۲ | Recruited bone marrow derived cells, local stromal cells and IL-17 at the front line of resistance development to anti-VEGF targeted therapies | Darvishi, B., Majidzadeh-A, K., Ghadirian, R., Mosayebzadeh, M., Farahmand, L. | Life Sciences | 2019 |
| ۴۳ | A review on the role of VEGF in tamoxifen resistance | Mansouri, S., Feizi, N., Mahdi, A., Majidzadeh-A, K., Farahmand, L. | Anti-Cancer Agents in Medicinal Chemistry | 2018 |
| ۴۴ | Stemness phenotype in tamoxifen resistant breast cancer cells may be induced by interactions between receptor tyrosine kinases and ERalpha-66 | Farahmand, L., Mansouri, S., Jafarbeik-Iravani, N., Teymourzadeh, A., Majidzadeh-A, K. | Recent Patents on Anti-Cancer Drug Discovery | 2018 |
| ۴۵ | Probable mechanisms involved in immunotoxin mediated capillary leak syndrome (CLS) and recently developed countering strategies | Darvishi, B., Farahmand, L., Jalili, N., Majidzadeh-A, K. | Current Molecular Medicine | 2018 |
| ۴۶ | Clinical evidence on the magnitude of change in growth pathway activity in relation to tamoxifen resistance is required | Mansouri, S., Farahmand, L., Teymourzadeh, A., Majidzadeh-A, K. | Current Cancer Drug Targets | 2018 |
| ۴۷ | Significant role of MUC1 in development of resistance to currently existing anti-cancer therapeutic agents | Farahmand, L., Merikhian, P., Jalili, N., Darvishi, B., Majidzadeh-A, K. | Current Cancer Drug Targets | 2018 |
| ۴۸ | Unique CD44 intronic SNP is associated with tumor grade in breast cancer: A case control study and in silico analysis | Esmaeili, R., Abdoli, N., Yadegari, F., (...), Kaviani, A., Majidzadeh-A, K. | Cancer Cell International | 2018 |
| ۴۹ | The effect of mesenchymal stem cell-conditioned medium on proliferation and apoptosis of breast cancer cell line | Farahmand, L., Esmaeili, R., Eini, L., Majidzadeh-A, K. | Journal of Cancer Research and Therapeutics | 2018 |
| ۵۰ | Monoclonal antibody-based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER | Moradi-Kalbolandi, S., Hosseinzade, A., Salehi, M., Merikhian, P., Farahmand, L. | Journal of Pharmacy and Pharmacology | 2018 |
| ۵۱ | Functionalised nanomaterials for eradication of CSCs, a promising approach for overcoming tumour heterogeneity | Farahmand, L., Darvishi, B., Salehi, M., Samadi Kouchaksaraei, S., Majidzadeh-A, K. | Journal of Drug Targeting | 2018 |
| ۵۲ | Self-filling microwell arrays (SFMAs) for tumor spheroid formation | Seyfoori, A., Samiei, E., Jalili, N., (...), Majidzadeh-A, K., Akbari, M. | Lab on a Chip | 2018 |
| ۵۳ | Challenges of endocrine therapy in breast cancer | Mansouri, S., Teymourzadeh, A., Farahmand, L., Majidzadeh-A, K. | Cancer Genetics and Psychotherapy | 2017 |
| ۵۴ | MED1 may explain the interaction between receptor tyrosine kinases and ERalpha66 in the complicated network of Tamoxifen resistance | Mansouri, S., Naghavi-al-Hosseini, F., Farahmand, L., Majidzadeh-A, K. | European Journal of Pharmacology | 2017 |
| ۵۵ | Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor jb transcription factor decoy oligodeoxynucleotides | Farahmand, L., Darvishi, B., Majidzadeh-A, K. | Drug Delivery | 2017 |
| ۵۶ | The A-kinase anchoring proteins correlation with disease free survival in breast cancer | Esmaeili, R., Samadi, T., Abdoli, N., (...), Farahmand, L., Salehi, M. | Tehran University Medical Journal | 2017 |
| ۵۷ | NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer | Darvishi, B., Farahmand, L., Eslami-S, Z., Majidzadeh-A, K. | Tumor Biology | 2017 |
| ۵۸ | Investigating Prevalence and Pattern of Long-term Cardiovascular Disorders in Sulphur Mustard-exposed Victims and Determining Proper Biomarkers for Early Defining, Monitoring and Analysis of Patients' Feedback on Therapy | Darvishi, B., Panahi, Y., Ghanei, M., Farahmand, L. | Basic and Clinical Pharmacology and Toxicology | 2017 |
| ۵۹ | Naturally occurring compounds acting as potent anti-metastatic agents and their suppressing effects on Hedgehog and WNT/beta-catenin signalling pathways | Farahmand, L., Darvishi, B., Majidzadeh-A, K., Madjid Ansari, A. | Cell Proliferation | 2017 |
| ۶۰ | Extremely low frequency magnetic field enhances glucose oxidase expression in Pichia pastoris GS115 | Madjid Ansari, A., Majidzadeh-A, K., Darvishi, B., (...), Farahmand, L., Norouzian, D. | Enzyme and Microbial Technology | 2017 |